by Precedence Research a new report on dermal fillers market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future. The global dermal fillers market size was valued at US$ 6.7 billion in 2021. The global dermal fillers market is projected to reach US$ 13.4 billion by 2030, registering a compound annual growth rate (CAGR) of 8.01% during the forecast period from 2022 to 2030.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/2100
The global dermal fillers market report offers various segments analysis by size, trends, growth factors, opportunities and key country outlook to 2030. The report offers a detailed analysis and information as per dermal fillers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
Dermal Fillers Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 7.24 Billion |
| Market Size by 2030 | USD 13.4 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 8.01% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Material, Product, Drug Type, Application, End User, and Geography |
The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Read Also@ Cosmeceuticals Market Size to Hit Around US$ 103.9 billion by 2030
Some of the prominent players in the dermal fillers market include:
- AbbVie, Inc.
- HUADONG MEDICINE CO., LTD
- BIOPLUS CO., LTD.
- TEOXANE LABORATORIES
- BIOHA LABORATORIES
- Prollenium Medical Technologies
- Galderma
- Merz Pharma
- Suneva Medical
- BIOXIS pharmaceuticals
Dermal Fillers Market Segmentation
By Material
- Hyaluronic acid
- Calcium hydroxyl apatite
- Poly-L-lactic Acid
- PMMA (Poly(methyl methacrylate))
- Fat Fillers
- Others
By Product
- Non-biodegradable
- Biodegradable
- Temporary biodegradable
- Semi-Permanent biodegradable
By Drug Type
- Branded
- Generic
By Application
- Wrinkle Correction Treatment
- Scar treatment
- Lip enhancement
- Restoration of volume
- Others
By End User
- Specialty and Dermatology Clinics
- Clinics and Hospitals
- Others
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Key Questions are
- What are the key factors influencing the dermal fillers market in each region?
- How much value will the global market generate by the end of the forecast period?
- What will be the CAGR of the global market between 2022 and 2030?
- What would be the Y-o-Y growth trend of the global market between 2022 and 2030?
- What is the future scope and current trends in technologies of the global market?
- What is the revenue of the global market based on segments?
- Which key strategies are used by top players of the global market?
- Which are the leading companies in the global market?
- What are the essential strategies by key stakeholders in the market to expand their geographic presence?
- What are the major advancements witnessed in the global market?
Research Objectives and Research Approach
The comprehensive report on the global dermal fillers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global dermal fillers market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global dermal fillers market in terms of type, application, region and others. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global market.
Why should you invest in this report?
If you are aiming to enter the global dermal fillers market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for dermal fillers are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dermal Fillers Market
5.1. COVID-19 Landscape: Dermal Fillers Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dermal Fillers Market, By Material
8.1. Dermal Fillers Market, by Material, 2022-2030
8.1.1. Hyaluronic acid
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Calcium hydroxyl apatite
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Poly-L-lactic Acid
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. PMMA (Poly(methyl methacrylate))
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Fat Fillers
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dermal Fillers Market, By Product
9.1. Dermal Fillers Market, by Product, 2022-2030
9.1.1. Non-biodegradable
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Biodegradable
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dermal Fillers Market, By Drug Type
10.1. Dermal Fillers Market, by Drug Type, 2022-2030
10.1.1. Branded
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Generic
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dermal Fillers Market, By Application
11.1. Dermal Fillers Market, by Application, 2022-2030
11.1.1. Wrinkle Correction Treatment
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Scar treatment
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Lip enhancement
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Restoration of volume
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Dermal Fillers Market, By End User
12.1. Dermal Fillers Market, by End User, 2022-2030
12.1.1. Specialty and Dermatology Clinics
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Clinics and Hospitals
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Others
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. OSAT
Chapter 13. Global Dermal Fillers Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Material (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Material (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Material (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Material (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.2.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Material (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.2.7. Market Revenue and Forecast, by Application (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Material (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.2.10. Market Revenue and Forecast, by Application (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Material (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Material (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Material (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.3.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Material (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Material (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Material (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Material (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Material (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.4.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Material (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Material (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Material (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Material (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Material (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.5.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Material (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Material (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. AbbVie, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. HUADONG MEDICINE CO., LTD
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. BIOPLUS CO., LTD.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. TEOXANE LABORATORIES
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. BIOHA LABORATORIES
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Prollenium Medical Technologies
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Galderma
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Merz Pharma
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Suneva Medical
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. BIOXIS pharmaceuticals
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/2100
Our Press Release@ https://www.precedenceresearch.com/press-releases
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
